KemPharm Webcast on VirtualInvestorConferences.com Now Available for On-Demand Viewing
Virtual Conference Highlights:
- On track to file for approval of its lead product candidate, KP415, which is intended for the treatment of attention deficit hyperactivity disorder (ADHD), as soon as the first quarter of 2019;
- Added new prodrug product candidate, KP879, which is intended for the treatment of stimulant use disorder (SUD);
- Announced license agreement with KVK Tech for
U.S.rights to commercialize FDA-approved APADAZ®;
- Announced technology collaboration with twoXAR, Inc. to develop novel prodrugs for multiple indications; and
- Provided an update on the partnering process for KP415 and KP484
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
Caution Concerning Forward Looking Statements:
This press release may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, and can be identified by the use of words such as "may," "will," "expect," "project," "estimate," "anticipate," "plan," "believe," "potential," "should," "continue" or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to
View original content to download multimedia:http://www.prnewswire.com/news-releases/kempharm-webcast-on-virtualinvestorconferencescom-now-available-for-on-demand-viewing-300763200.html